Health Condition 1: L010- Impetigo
Conditions
Interventions
Intervention1: Ozenoxacin ,Fusidic Acid: Ozenoxacin 1% local application two times daily for seven days and Fusidic Acid 2% local application three times daily for seven days.
Control Intervention1:
Sponsors
Ranjan Rashmiraj Sahu
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with clinical diagnosis of primary Impetigo. 2. Impetigo of mild( 3. Total affected area at baseline not exceeding 100 cm2 or more than 2% of the BSA. 4. Age between 2 month to 15 years. 5. Skin infection rating score more than equal to four. 6. Parent or legal guardian willing to comply with the protocol.
Exclusion criteria
Exclusion criteria: 1.Patient age less than 2 month and more than 15 years. 2.Impetigo of severe( >20 lesions)variety and which warrants systemic therapy. 3.Hypersensitivity to fusidic acid,mupirocin and ozenoxacin. 4.Pre existing eczematous dermatitis with clinical evidence of secondary infection or the presence of a bacterial infection that could not be appropriately treated by a topical antibiotic. 5.use of topical or systemic antibiotic or corticosteroids within one week of baseline.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin Infection Rating ScaleTimepoint: On 14th day | — |
Secondary
| Measure | Time frame |
|---|---|
| Skin Infection Rating ScaleTimepoint: 7th day | — |
Countries
India
Contacts
Public ContactDr Swapnarani Behera
SCB medical college & hospital,Cuttack
Outcome results
None listed